American Shared Hospital Services (AMS)

American Shared Hospital Services' stock price has experienced fluctuations and a general decline over the past year. In Q1 2025, AMS reported increased revenues but an increased net loss due to reduced Gamma Knife volumes and increased direct patient services revenues. The company held its Q2 2025 earnings call on August 13, 2025. In Q3 2025, AMS reported increased revenue and improved gross margins, with narrowed operating losses and increased adjusted EBITDA, despite a net loss. As of November 25, 2025, the stock price increased, but the overall moving average trend leans bearish.

Specific information detailing the demand seasonality for American Shared Hospital Services' products and services is not publicly available in the provided search results.

American Shared Hospital Services (AMS) is a publicly traded healthcare company specializing in advanced technology solutions for stereotactic radiosurgery and radiation therapy, operating in leasing and direct patient care services. AMS provides state-of-the-art medical equipment to hospitals and medical centers through financing solutions. The company offers Gamma Knife systems for non-invasive treatment, Proton Beam Radiation Therapy (PBRT) systems, Intensity Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT), advanced digital linear accelerators and MR Guided Radiation Therapy Linacs, brachytherapy systems, and direct patient care services through single-unit Gamma Knife facilities.

American Shared Hospital Services provides radiation therapy services both domestically and internationally and is headquartered in San Francisco, California. In the United States, the company has expanded its direct patient care footprint, including the acquisition of three radiation therapy centers in Rhode Island and plans for a fourth center in Bristol, Rhode Island, and a proton beam radiation treatment center in Johnston, Rhode Island. Internationally, AMS has an active presence, particularly in Latin America, including direct patient services revenue from operations in Peru and Ecuador, and has expanded into Mexico, with a new radiation therapy treatment center in Puebla and a planned Gamma Knife Center in Guadalajara expected to start in Q2 2026.

Information regarding specific events that have affected American Shared Hospital Services' brand reputation in the past year is not readily available in the provided search results.

American Shared Hospital Services' stock ownership includes institutional, retail, and individual investors. Institutional investors own approximately 11.92% to 23.16% of the stock, with major holders including Dimensional Fund Advisors LP and Vanguard Group Inc. Insiders hold a significant portion, approximately 23.80% to 25.51% of the stock, with Raymond Stachowiak owning the most shares. Public companies and individual investors collectively own approximately 62.57% of the company's stock.